The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Mallinckrodt Public Limited Company (NYSE: MNK) who purchased shares between February 28, 2018 and July 16, 2019. The action, which was filed in the United States District Court for the Southern District of New York, alleges that the Company violated federal securities laws.
In particular, the Mallinckrodt Public lawsuit alleges that (i) Acthar posed significant safety concerns that rendered it a non-viable treatment for ALS; (ii) accordingly, Mallinckrodt overstated the viability of Acthar as an ALS treatment; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
Shareholders have until September 24, 2019 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
To learn more and keep informed, complete this form >